ICAGEN, INC.
Profile
Company Names
ICAGEN, INC.
XRPRO SCIENCES, INC.
CALDERA PHARMACEUTICALS INC
Addresses
4222 EMPEROR BLVD., SUITE 350, RESEARCH TRIANGLE PARK, DURHAM, NC 27703
4222 EMPEROR BLVD., SUITE 350, DURHAM, NC 27703
ONE KENDALL SQUARE, SUITE B2002, BOSTON, MA 02139
ONE KENDALL SQUARE, SUITE B2002, CAMBRIDGE, MA 02139
278 DP ROAD, SUITE D, LOS ALAMOS, NM 87544
278 DP ROAD SUITE D, LOS ALAMOS, NM 87544
Phone Numbers
919-941-5206
(919) 941-5206
(617) 631-8825
(505) 661-2420
505-601-2420
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$27,482,950.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2018-08-31
$7,250,000.00
$7,250,000.00
$0.00
Debt
8
2018-08-13
$500,000.00
$1,500,000.00
$1,000,000.00
Debt
7
2018-04-04
$2,000,000.00
$4,000,000.00
$2,000,000.00
Equity
6
2017-05-15
$2,000,000.00
$2,000,000.00
$0.00
Debt
5
2017-04-12
$1,500,000.00
$1,500,000.00
$0.00
Debt
4
2016-06-27
$1,145,000.00
$1,145,000.00
$0.00
Debt
3
2014-12-10
$8,855,000.00
$8,855,000.00
$0.00
Equity
2
2013-04-17
$3,135,000.00
$5,000,000.00
$1,865,000.00
Equity
1
2011-05-13
$1,097,950.00
$2,000,000.00
$902,050.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD
CUNNINGHAM
EXECUTIVE OFFICER
CLIVE
KABATZNIK
DIRECTOR
MARK
KORB
EXECUTIVE OFFICER
VINCENT
PALMIERI
DIRECTOR
EDWARD
ROFFMAN
DIRECTOR
MICHAEL
TAGLICH
DIRECTOR
MANHATTAN + ISLAND DEVELOPMENT CORP LLC
| CHF TECHNOLOGIES INC
| AUTONET INVESTORS LLC
| BIOVENTRIX INC
| BRIDGELINE DIGITAL, INC.
| XRPRO SCIENCES, INC.
| ICAGEN, INC.
| AUTONET MOBILE INC
| TPE - NMC LEASECO., LLC
| BROOKLYN BOULDERS INVESTMENTS LLC
| BIOVENTRIX INVESTORS, LLC
| BIOVENTRIX, INC.
| TPE-FIESTA LEASECO., LLC
| MARE ISLAND DRY DOCK INVESTMENT LLC
BENJAMIN
WARNER
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Debt
2018-08-31
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Debt
2018-08-13
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2018-04-04
D
BIOTECHNOLOGY
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Debt
2017-05-15
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Debt
2017-04-12
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Debt
2016-06-27
D/A
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2014-12-10
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2014-12-10
D/A
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2013-04-17
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2013-04-17

